Addressing Vaccine Hesitancy Through Better Pharmacy Conversations
Pharmacists are often the most accessible health professionals in Australia. A person may visit a pharmacy in suburban Melbourne for a flu vaccination, ask about a COVID-19 booster while collecting a prescription in Sydney, or rely on a rural pharmacy when the nearest medical practice is several towns away. These everyday encounters give pharmacists a valuable opportunity to understand concerns and support informed immunisation decisions.
Vaccine hesitancy rarely comes from a single cause. It may involve fear of adverse effects, previous negative healthcare experiences, religious or cultural beliefs, confusing social media claims, cost concerns, or uncertainty about eligibility under the National Immunisation Program (NIP). Effective communication starts with curiosity and respect, then turns reliable evidence into practical guidance that fits the person’s circumstances.
| Communication approach | Likely effect | Better pharmacy practice |
|---|---|---|
| Correcting misinformation immediately | Can make people defensive | Ask what they have heard and why it matters to them |
| Giving a long list of facts | May increase confusion | Focus on the person’s main concern and use plain language |
| Treating hesitation as refusal | Closes the conversation | Recognise uncertainty as an opportunity for dialogue |
| Using pressure or shame | Damages trust | Support informed choice while clearly explaining risks |
| Ending with general advice | Can lead to delay | Offer a specific next step, such as checking eligibility or booking |
Read Hesitancy Before Responding
The first task is to identify what sits behind the hesitation. “I am not sure” might mean the person is worried about a sore arm, has heard a frightening story online, cannot afford a private vaccine, or is unsure whether vaccination is recommended for their age or condition. A brief, open question such as “What is your biggest concern?” can reveal more than a prepared explanation.
Pharmacists should listen for confidence, convenience and complacency. Someone may believe vaccines work but lack time to book an appointment. Another person may accept childhood immunisation but question adult boosters. A patient with chronic disease may be concerned about interactions or feel overwhelmed by several recommendations. Reflecting their concern before offering information demonstrates that the conversation is collaborative rather than corrective.
Avoid labelling a person as “anti-vaccine” too quickly. Hesitancy exists on a spectrum, and views can change according to the vaccine, life stage and current circumstances. A parent who delays an influenza vaccine may still support routine childhood vaccines, while an older adult may accept shingles vaccination but decline a COVID-19 dose after a difficult previous reaction.
Build Trust Through Local Context
Trust is strengthened when advice reflects the Australian healthcare environment. Explain how the Australian Immunisation Register (AIR), the NIP and state or territory programs may affect eligibility, records and access. Funding and pharmacist administration rules can change, so checking current local requirements is safer than relying on memory. If a vaccine is not funded, discuss the cost clearly and identify whether a GP, Aboriginal Community Controlled Health Service or public clinic may provide another pathway.
Access also differs greatly between metropolitan and regional communities. A pharmacy in Brisbane may offer several vaccination appointments each day, while a patient in the Northern Territory or a remote Western Australian community may need to coordinate immunisation with outreach services, work travel or a visiting nurse. In rural areas, pharmacists can help reduce practical barriers by checking stock, confirming appointment times and explaining what documentation is required.
Cultural respect is equally important. Dietary practices, family decision-making and previous experiences with institutions can shape health choices. A conversation with a newly arrived family in western Sydney may require an interpreter, while a person in a culturally diverse Melbourne suburb may prefer information that acknowledges religious observances and community networks. Even an ordinary discussion about familiar foods and traditions, such as these spinach and mozzarella calzoni, can remind clinicians that health communication works best when it connects with people’s everyday lives rather than treating them as abstract cases.
Use A Clear, Respectful Conversation
A useful structure is ask, acknowledge, advise and agree. Ask permission to discuss the vaccine. Acknowledge the concern without endorsing inaccurate information. Advise with a concise explanation tailored to the person’s age, health and exposure risk. Agree on a next step, which may be vaccination today, a follow-up appointment or time to review trustworthy information.
Permission-based language can reduce resistance. “Would it be helpful if I explained what we know about common reactions?” gives the person some control. The pharmacist can then distinguish expected effects, such as temporary arm discomfort or fatigue, from symptoms that require medical review. Clear safety-netting is reassuring because it shows that the patient will not be left alone if they feel unwell.
Reflective listening is especially useful when emotions are strong. Statements such as “You are worried because your child had a fever after the last injection” or “You want to avoid another difficult recovery” show that the pharmacist has heard the underlying concern. The response should remain calm and factual, without sarcasm, ridicule or an attempt to win an argument.
Explain Benefits And Risks Plainly
Risk communication should use absolute terms where possible. Rather than saying a vaccine “reduces risk significantly”, explain what that means for the relevant disease, age group or clinical condition when reliable figures are available. Avoid promising complete protection. Vaccination may reduce the chance of infection, severe illness, hospitalisation or complications, while effectiveness can vary according to the vaccine and circulating strains.
People often compare the immediate visibility of a vaccine reaction with the less visible possibility of infection. Pharmacists can make that comparison understandable: a sore arm may be noticeable for a day or two, whereas influenza, pneumococcal disease or shingles can cause prolonged illness and disruption. The aim is not to frighten the patient, but to put short-term reactions and disease consequences into the same decision.
Use everyday language instead of technical terms. “The immune system practises recognising the infection” is usually clearer than a detailed description of antigen presentation. Explain that monitoring continues after vaccines are introduced and that uncommon adverse events are investigated through established safety systems. If the person has a history of severe allergy, pregnancy, immunocompromise or a previous serious reaction, pause and follow current clinical guidance rather than improvising.
Practical Conversation Aids
A small set of prompts can help pharmacy teams maintain consistency during busy periods. These prompts should support professional judgement, not turn a sensitive conversation into a script.
- “What have you heard about this vaccine?”
- “What concerns you most: safety, effectiveness, cost or access?”
- “Would you like a short explanation or more detail?”
- “What would help you feel ready to decide?”
Written resources should be short, current and easy to read. A QR code linking to an official Australian health source can be useful, provided the pharmacist explains why the source is reliable. Offer translated material or an interpreter when appropriate, and allow a support person to participate with the patient’s consent.
The following actions help convert a respectful discussion into safe care:
- Check the AIR record and relevant vaccination history.
- Confirm eligibility, contraindications and current product guidance.
- Explain expected reactions and when to seek help.
- Record the discussion, consent and follow-up plan accurately.
Respond To Misinformation And Delay
When a patient repeats a false claim, begin with the reason it seems convincing. Social media posts often combine a genuine event with an unsupported conclusion, or use personal stories to imply that one experience proves a general rule. Asking where the information came from and what the person found persuasive creates space to examine it without humiliating them.
A simple correction works best when it is brief and repeated consistently. State the fact, explain the relevant evidence and return to the patient’s concern. For example: “Reports of adverse events are investigated, but a report after vaccination does not by itself prove that the vaccine caused the event. Let us look at what is known about this product and your medical history.” Avoid repeating a sensational claim so often that it becomes more memorable than the correction.
Some people need time. If immediate vaccination is unsuitable, provide a specific review plan rather than ending with “think about it”. Arrange a later conversation, suggest an appointment with the GP, or give the patient a reliable resource to read. Document the decision and any follow-up needed, particularly where the person has a higher risk of complications from infection.
Hesitancy can also be linked to broader distress, poverty or mistrust of healthcare. A patient managing opioid dependence may have missed routine care because of stigma or unstable housing. Pharmacists seeking a wider perspective on this work can explore community pharmacy support, including the importance of practical, non-judgemental engagement. Vaccine communication is more effective when it sits within a relationship that addresses the person’s wider health needs.
Turn Good Conversations Into Action
Pharmacy teams can make immunisation conversations part of routine care rather than a seasonal campaign. Prompt patients during medication reviews, chronic disease support, diabetes care and opioid treatment services. A simple workflow can flag vaccination status, identify barriers and direct the person to the right clinician or service without making every interaction feel like a sales pitch.
Training should cover clinical updates and communication skills together. Role-play can prepare staff for common situations: a parent concerned about fever, an older adult comparing online stories, a patient asking about vaccine ingredients, or a person who cannot afford a privately supplied product. Team members should know when to answer, when to consult a pharmacist, when to use an interpreter and when to refer to a GP or emergency service.
Professional reflection also matters. Pharmacists can review which questions lead to meaningful conversations, whether patients receive consistent explanations and whether follow-up plans are completed. Resources from experienced healthcare writers and practitioners, such as Johnathan Laird, may prompt broader thinking about communication, pharmacy practice and patient-centred care.
Start with one practical change this week: add an open-ended question to vaccination consultations, check the latest Australian eligibility guidance, and create a clear follow-up process for people who are undecided. When pharmacists listen carefully, explain honestly and make access easier, vaccine conversations become a trusted part of everyday healthcare rather than a confrontation at the counter.